Chief Accounting Officer · Summit Therapeutics Inc. · Common Stock
Side
A
Value
—
Shares
100.0K
Price
—
Executed
Oct 8, 2026
Disclosed
Oct 14, 2026
Disclosure timeline6 days from execution to publication · legal deadline 2 business days
Oct 8 executedOct 14, 2026 disclosed
SMMT · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 62.1% of prior position
Filing timing+6 / 15
Disclosed 4 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Anand Bhaskar filed this Form 4 reporting a grant or award of SMMT on Oct 8, 2026. It became public on Oct 14, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Accounting Officer
Anand Bhaskarcik:0001890784
Issuer
Summit Therapeutics Inc.cik:0001599298
Revision history · 0
No field has changed since this record was first ingested.
